Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. V. Gil Navarro"'
Autor:
R. Valencia-Martín, V. Gonzalez-Galan, R. Alvarez-Marín, A. M. Cazalla-Foncueva, T. Aldabó, M. V. Gil-Navarro, I. Alonso-Araujo, C. Martin, R. Gordon, E. J. García-Nuñez, R. Perez, G. Peñalva, J. Aznar, M. Conde, J. M. Cisneros, In representation of A. baumannii eradication program
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-11 (2019)
Abstract Background Acinetobacter baumannii causes frequently nosocomial infections worldwide. Its ability to survive on dry surfaces facilitates its spread and the persistence of endemic situations, especially in the intensive care units (ICUs). The
Externí odkaz:
https://doaj.org/article/c5ea32a3dcc64874b2ced43ea8f0fca4
Autor:
María José Mayorga-Buiza, Esperanza Castillo-Ojeda, M Rivero-Garvía, M J Gómez-Gómez, M V Gil-Navarro, Cecilia Martín-Gandul, Manuel E. Jiménez-Mejías, Francisco Javier Márquez-Rivas
Publikováno v:
Acta Neurochirurgica. 158:1837-1843
Evidence for the effectiveness of linezolid in neurosurgical infections (NSIs) is growing. The comfortable oral dosage and tolerance of linezolid opens the possibility for sequential antimicrobial treatment (SAT) in stable patients after a period of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaea916d65d2a21cde18d1e07904ca93
https://doi.org/10.1007/s00701-016-2915-0
https://doi.org/10.1007/s00701-016-2915-0
Autor:
M V Gil Navarro, R Martín Bermúdez, L Herrera Hidalgo, L. Martín Villén, AB Guisado Gil, Y. Corcía Palomo
Publikováno v:
European Journal of Clinical Pharmacology. 74:1093-1094
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a31845aa4874dedec856188c76ffc730
https://doi.org/10.1007/s00228-018-2473-x
https://doi.org/10.1007/s00228-018-2473-x
Autor:
M D, Santos-Rubio, R, Marín-Gil, R, Muñoz-de la Corte, M D, Velázquez-López, M V, Gil-Navarro, F J, Bautista-Paloma
Publikováno v:
Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial. 31(2)
To proactively identify risks in the preparation of intravenous cytostatic drugs, and to prioritise and establish measures to improve safety procedures.Failure Mode Effect Analysis methodology was used. A multidisciplinary team identified potential f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08fb6708b74abc85f55930e4a8b559c0
https://pubmed.ncbi.nlm.nih.gov/26476875
https://pubmed.ncbi.nlm.nih.gov/26476875
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manuel E. Jiménez-Mejías, M. V. Gil Navarro, M. J. Gómez-Gómez, Jerónimo Pachón, Hospitale Universitarios Virgen del Rocío, Carlos Ortiz-Leyba, Emilio García-Cabrera, Elisa Cordero
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 29(7)
We performed a retrospective and observational study of 51 patients treated with tigecycline, as the treatment for nosocomial infections due to multidrug-resistant microorganisms, to evaluate the superinfection rate and their etiologies. Superinfecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c385d27934e50d4ef5daa74ed89d802
https://pubmed.ncbi.nlm.nih.gov/20473700
https://pubmed.ncbi.nlm.nih.gov/20473700
Autor:
J, Galindo-Ocaña, M V, Gil-Navarro, J S, García-Morillo, M, Bernabeu-Wittel, M, Ollero-Baturone, M A, Ortiz-Camuñez
Publikováno v:
Revista clinica espanola. 210(6)
To determine the prevalence of relevant drug-drug interactions (DDIs) and associated predictor factors in a sample of patients with multiple complex chronic diseases (polypathological patients) receiving multiple drug therapy. Our secondary objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96b8de03ef5c2c68b362ff3e19da115d
https://pubmed.ncbi.nlm.nih.gov/20434722
https://pubmed.ncbi.nlm.nih.gov/20434722
Autor:
M V, Gil-Navarro, R, Muñoz-Corte, M, Herrero Romero, M D, Santos Rubio, E, Cordero Matía, J, Bautista Paloma
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 33(1)
To determine the effectiveness of the intervention of a multidiscipline antimicrobial control group in the correct prescription of Ertapenem.A four-month long, prospective study into prescriptions for Ertapenem was carried out in a third-level hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c98450d812aa2e224270ae904bd20eb8
https://pubmed.ncbi.nlm.nih.gov/19401098
https://pubmed.ncbi.nlm.nih.gov/19401098
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 32(4)
To define the role of those drugs available for hepatitis B treatment and analyse current treatment guides prepared by the leading scientific societies in the field.Bibliographic searches were carried out in the databases PubMed and EMBASE, using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc2e7dd4dfab7abac992620b26f2f749
https://pubmed.ncbi.nlm.nih.gov/19128731
https://pubmed.ncbi.nlm.nih.gov/19128731
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.